Articles Tagged With:
-
Adjunctive Dexamethasone Is Not Beneficial for HIV Patients with Tuberculous Meningitis
A randomized, placebo-controlled clinical trial in human immunodeficiency virus-positive adults with tuberculous meningitis found no benefit for adjunctive dexamethasone in survival or risk of neurologic immune reconstitution inflammatory syndrome (IRIS). Side effects were similar to placebo.
-
Healing HCWs — Including IPs — Is a National Priority for CDC, NIOSH
Burnout among all stripes of healthcare workers — including infection preventionists — has become a dire situation warranting national action. Accordingly, the Centers for Disease Control and Prevention and the National Institute for Occupational Safety and Health have released new research and emphasized available resources to raise awareness for an ambitious “system change” in healthcare delivery.
-
Comparing the Safety of Cefepime and Piperacillin-Tazobactam: The ACORN Trial
Qian and colleagues conducted a pragmatic, open-label, randomized clinical trial to determine whether the empiric use of piperacillin-tazobactam or cefepime affects the risk of acute kidney injury (AKI) or neurological dysfunction in patients hospitalized for sepsis. The study showed no significant difference in the incidence of AKI between groups, but rates of neurological dysfunction were slightly higher in patients treated with cefepime.
-
CDC Draft Revamps Airborne Precautions, Calls for N95s
New draft patient isolation guidelines recently approved by advisors to the Centers for Disease Control and Prevention call for scrapping the “outdated dichotomy” of droplet/airborne precautions in favor of a “continuum” approach to stop transmission through the air.
-
Malaria in Pregnancy — Simplified Treatment Decisions
History, data, and international consensus lead to the same conclusion: Artemether-lumefantrine is the first choice for treatment of uncomplicated falciparum malaria in everyone, even pregnant women.
-
OCR Updates HIPAA Assessment Tool
The Office for Civil Rights has updated a self-assessment tool that covered entities can use to determine how well they are complying with HIPAA, and the new version presents an opportunity to see how useful the resource can be.
-
What to Expect After a HIPAA Violation
Discovering a HIPAA violation in your organization inevitably causes anxiety about what will follow and how bad the consequences can be. Understanding the process and what to expect can ease some of the worry and help you manage the process to the best possible resolution.
-
Plaintiff’s Failure to Follow Expert Disclosure Deadlines Results in Judgment for Defendants
As an initial, medical point, surgeons who often ask physicians in training to close surgical wounds after the procedure should take care to confirm the skill of the trainee and the quality of the result. But if such a procedure (or any procedure) leads to a medical malpractice case, experts are essential.
-
Appeals Court Clarifies Standard for Admissibility of Expert Opinion in Medical Malpractice Case
Cases involving expert opinions are sometimes referred to as “a battle of the experts” due to the degree of importance in medical malpractice cases and other matters involving technical, medical, and scientific issues. Judges are the gatekeepers of whether expert opinions are reliable enough to be admitted. As the Georgia Court of Appeals found, judges can sometimes get it wrong.
-
EDs Can Make Discharges Against Medical Advice Safer
There is a lack of evidence in the literature regarding effective interventions to prevent discharge against medical advice, according to a review of studies from 1989-2022. Emergency care providers should discuss prescriptions, follow-up appointments, and red-flag signs that indicate patients should return to the ED — just as they would with any patient about to be discharged from the department.